Selank enkephalin research is one of the less widely known but mechanistically important research areas for the peptide, extending the Selank research cluster into the endogenous opioid system biology that contributes to the integrated pharmacological profile of the compound alongside the GABAergic and BDNF effects covered elsewhere in the cluster.
Selank Enkephalin Research: Endogenous Opioid System Animal Model Literature
Selank · Published April 14, 2026 · Updated May 18, 2026 · 7 min read
Quick Answer
Selank enkephalin research examines endogenous opioid system interactions and delta opioid receptor signaling in rodent models. Studies measure enkephalin levels, opioid receptor expression, and analgesic biomarkers across standardized opioid pathway research protocols using this synthetic heptapeptide. For research use only, not for human consumption.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
- The Endogenous Opioid System
- Enkephalin Metabolism and Selank
- Anxiolytic Effects and Opioid System Contribution
- Mood and Stress Research
- Analgesic Research Context
- Delta Opioid Receptor Selectivity
- Relationship to Other Cluster Topics
- Research Peptide Referenced
- Related Research Reading
- Related Research Articles
- Explore Related Products
- Frequently Asked Questions
- Glossary
Frequently Asked Questions
What is Selank in research contexts?
+
Selank is a synthetic heptapeptide derived from the natural immunomodulatory tetrapeptide tuftsin and developed in Russian neuropeptide research. It is studied in preclinical models for anxiolytic effects, GABAergic modulation, BDNF expression, and immunomodulatory activity.
How does Selank interact with the endogenous opioid system?
+
Published research suggests Selank modulates enkephalin signaling through delta opioid receptor pathways, contributing to its anxiolytic effects. The peptide's structure and the opioid system interaction distinguish it from classical opioid agonists.
What enkephalin endpoints are measured with Selank?
+
Endpoints include brain region enkephalin levels, delta opioid receptor expression and binding, naloxone reversibility of behavioral effects, and integrated assessment of how opioid system modulation contributes to Selank's overall pharmacology.
Is Selank approved for human use?
+
No. Selank is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.
Glossary
Key terms used in this article.
- Tuftsin
- An endogenous tetrapeptide (Thr-Lys-Pro-Arg) liberated from the Fc domain of immunoglobulin G, the structural basis for Selank.
- GABAergic
- Pertaining to neurons, synapses, or signaling pathways using gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter.
- Anxiolytic
- Pertaining to compounds that reduce anxiety in behavioral or physiological studies.
- BDNF
- Brain-derived neurotrophic factor, a key neurotrophin supporting neuronal survival, synaptic plasticity, and learning.
- Heptapeptide
- A peptide consisting of seven amino acid residues; both Selank and Semax are heptapeptides.
- Enkephalin
- Endogenous opioid pentapeptides (Met-enkephalin, Leu-enkephalin) that act primarily on delta and mu opioid receptors.
- Delta Opioid Receptor
- One of three classical opioid receptors, expressed in brain regions involved in mood, anxiety, and analgesia.
More from the Blog
Continue exploring research insights and updates.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
